Tempus Wealth Planning, LLC Krystal Biotech, Inc. Transaction History
Tempus Wealth Planning, LLC
- $360 Million
- Q2 2025
A detailed history of Tempus Wealth Planning, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Tempus Wealth Planning, LLC holds 2,379 shares of KRYS stock, worth $357,206. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,379Holding current value
$357,206% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding KRYS
# of Institutions
332Shares Held
24.2MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$593 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$424 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$410 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$184 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$143 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.85B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...